Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy

Thoracic and Cardiovascular Surgeon

Volumn 51, Issue 4, 2003, Pages 185-189

  Gansera, Brigitte ^a   Schmidtler, F ^a   Spiliopoulos, K ^a   Angelis, I ^a   Neumaier Prauser, P ^a   Kemkes, B M ^a  

^a KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

Clopidogrel and CABG

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ADULT; AGED; AORTA CLAMPING; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTENSIVE CARE UNIT; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAPHENOUS VEIN GRAFT; SURGICAL MORTALITY; THROMBOCYTE TRANSFUSION; THROMBOSIS;

AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD TRANSFUSION; CHEST TUBES; CORONARY ARTERY BYPASS; EMERGENCIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; REOPERATION; RETROSPECTIVE STUDIES; TICLOPIDINE;

EID: 0141960809     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42260     Document Type: Article

References (21)

1. Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antipletelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996; 334: 1084-1089
2. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998; 339: 1665-1671
3. Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, et al. Thrombotic thrombocytopenic purpura associated with ticlopidine: a view of 60 cases. Ann Intern Med 1998; 128: 541-544
4. Herbert JM, Frehel D, Vallee E, et al. Clopidogrel a novel antiplatelet and antithrombotic agent. Cardiovasc Drug Rev 1993; 11: 180-198
5. Harker LA, Boissel JP, Pilgrim AJ, et al. Comperative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. Clopidogrel versus aspirin in patients at risk of ischemic events. Drug Safety 1999; 21: 325-353
6. Taniuchi M, Kurz HI, Lasala JM. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 2001; 104: 539-543
7. Hankey GJ, Sudlow CIM, Dunbabin DW. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. Stroke 2000; 31: 1779-1784
8. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348: 1329-1339
9. Bertrand ME, Rupprecht H-J, Urban P, Gershlick AH, for the classic investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the Clopidogrel Aspirin Stent International cooperative study (CLASSICS). Circulation 2000; 102: 624-629
10. Muller C, Buttner HJ, Petersen J, Rosenkamm H. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. Circulation 2000; 101: 590-593
11. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 435: 494-502
12. Lytle BW, Cosgrove DM, Loop FD, Borsh J, Goormastic M, Taylor PC. Perioperative risk of bilateral internal mammary artery grafting: analysis of 500 cases from 1971-1984. Circulation 1986; 74 (Suppl III): 37-41
13. Gansera B, Günzinger R, Angelis I, et al. End of the millenium - end of single thoracic artery graft. Two thoracic arteries - standard for the next millenium? Early clinical results and analysis of risk factors in 1.487 patients with bilateral internal thoracic artery grafts. Thorac Cardiovasc Surg 2001; 49: 10-15
14. Klein M, Keith PR, Dauben HP, et al. Aprotinin counterbalances and increased risk of perioperative hemorrhage in CABG patients pretreated with aspirin. Eur J Cardiothorac Surg 1998; 14: 360-366
15. 2YAC ADP receptor mediated signaling by the antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol 1999; 19: 2007-2011
16. Herbert JM, Savi P, Maffrand JP. Biochemical and pharmacological properties of clopidogrel: A new ADP receptor antagonist. Eur Heart J 1999; (Suppl A): A31-A40
17. Savcic M, Hauert J, Bachmann F, Wyld PJ, Geudelin B, Cariou R. Clopidogrel loading dose regimes: Kinetic profile of pharmodynamic response in healthy Subjects. Semin Thromb Hemost 1999; 25 (Suppl 2): 15-19
18. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Case Med 2001; 29: 2271-2275
19. Le Narz LA. Coronary artery bypass graft in abciximab-treated patients. Ann Thorac Surg 2000; 70: 38-42
20. Hongo RH, Ley J, Dick SE, et al. The effect of clopidogrel in combination with aspirin undergiven before coronary artery bypass grafting. IACC 2002; 40: 231-237
21. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2000; 36: 970-1062